Research Summary

NESCO Ltd. is a diversified Indian company headquartered in Mumbai. The company is primarily engaged in the business of real…

“Looking to the year ahead, we continue to see strong demand. We have positioned ourselves better to fulfil this demand…

Our growth aspirations are huge, and we are making all the right investments to ensure that we further cement our…

LT Foods Limited is one of the leading rice brands in India. The company focuses on the production and marketing…

“MSMEs in the A&D space have survived through tough times over the years— given the trifecta of low volumes, high…

While the Indian economy has been recording healthy growth, there are concerns for the external sector. With the global economy…

“The long-term trajectory again continues to be good. The pipeline continues to be strong. There are several large opportunities within…

“We are progressing well on our pipeline products. The number of filings in several of our key markets have been…

Going forward, the company’s margin expansions are going to be aided by the growing operational efficiencies, multiple price hikes, softening…

“Going ahead, the macroeconomic environment is expected to improve with inflation easing in December and the anticipated stimulus of the…

“Our engagements with Strategic Clients are progressively becoming more pertinent and partnership oriented. We are committed to investments in new-age…

“I am happy to report that our hospital business continued to deliver consistent performance in all key operational and financial…

“Our Q3 results reflect further infusion of energy into our business with strong portfolio of brands, delivering healthy results with…

“Improved affordability parameters from the longer-term perspective, persistence of flexible, hybrid work formats and sustained investments in infrastructure by the…

“We have started recovering our market shares and expect this journey to continue backed by exciting launches lined up over…

“The geopolitical risks continue, and the era of low energy and commodity prices may not come back in the near-term.…

The net interest margin will stay around the current levels. ROA also to stay around the current level that is…

“In FY24, Company’s profitability is expected to improve, driven by growth in Radiopharmaceuticals, Allergy Immunotherapy and CDMO Sterile Injectables businesses.…

“The distributor business has grown 50% in this period, which we are talking about from Q1 to Q3. Panel builders…

“I am delighted to report that for the second consecutive quarter, we have had record-breaking numbers with the highest-ever revenues…

“The company is looking for close to Rs. 500 Cr to Rs. 550 Cr of capex by March 2025 mainly…